Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine

NCT00435812 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2428

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: HEPLISAV and/or Placebo
BIOLOGICAL: Engerix-B

Sponsor

Dynavax Technologies Corporation